Kemnay Advisory Services’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.9K Buy
+441
New +$18.9K ﹤0.01% 577

Other funds holding URGN

Kemnay Advisory Services's URGN Position: Q3 2026 in Review

Kemnay Advisory Services opened a new position in UroGen Pharma (URGN) in Q3 2026: 441 shares worth $17.9K. The stake represents ﹤0.01% of the portfolio and ranks #577 among its holdings.

221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • Kemnay Advisory Services held 441 shares of UroGen Pharma worth $17.9K as of Q3 2026.
  • UroGen Pharma was a new Kemnay Advisory Services position in Q3 2026.
  • UroGen Pharma made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q3 2026, its #577 holding.
  • 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on Kemnay Advisory Services's 13F filing for Q3 2026, filed 16 Nov 2026.